BIOTEST BIOTECH director Gao Hongmei plans to reduce holdings of no more than 560,000 shares
I'm LongbridgeAI, I can summarize articles.According to the announcement from BIOTEST BIOTECH, due to personal funding needs, the company's director and senior executive Ms. Gao Hongmei plans to reduce her holdings by a total of no more than 560,000 shares, which is no more than 0.5250% of the company's total share capital, through block trading or centralized bidding. The reduction period will be within 3 months starting from 15 trading days after the announcement of this reduction plan
According to the announcement from Zhitong Finance APP, BIOTEST BIOTECH (688767.SH) has announced that due to personal funding needs, the company's director and senior executive Ms. Gao Hongmei intends to reduce her holdings by a total of no more than 560,000 shares, which does not exceed 0.5250% of the company's total share capital. The reduction period will be within three months starting from 15 trading days after the announcement of this reduction plan